Human recombinant interferon alpha-2a (r IFN alpha-2a) therapy suppresses hepatic triglyceride lipase, leading to severe hypertriglyceridemia in a diabetic patient.
Journal: 1994/December - American Journal of Gastroenterology
ISSN: 0002-9270
PUBMED: 7977268
Open in
PUBMED | Google Scholar | Wikipedia
Relations:
Citations
(1)
Diseases
(3)
Chemicals
(2)
Organisms
(1)
Anatomy
(1)
Similar articles
Articles by the same authors
Discussion board
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.